Andreas Bounas

528 total citations
19 papers, 345 citations indexed

About

Andreas Bounas is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Andreas Bounas has authored 19 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 7 papers in Hematology and 4 papers in Immunology. Recurrent topics in Andreas Bounas's work include Autoimmune and Inflammatory Disorders Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Andreas Bounas is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Andreas Bounas collaborates with scholars based in Greece, United States and Germany. Andreas Bounas's co-authors include Andrew P. Andonopoulos, Stamatis‐Nick C. Liossis, Christopher B. Ballas, D. Alexopoulos, J Christodoulou, S. Yarmenitis, Dimitrios Daoussis, Panagiotis Georgiou, Gikas Katsifis and A.P. Andonopoulos and has published in prestigious journals such as Quality of Life Research, Lara D. Veeken and Lupus.

In The Last Decade

Andreas Bounas

18 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Bounas Greece 8 143 136 123 77 66 19 345
Vasiliki Kalliopi Bournia Greece 8 91 0.6× 88 0.6× 103 0.8× 95 1.2× 33 0.5× 10 301
Raluca B Dumitru United Kingdom 10 180 1.3× 82 0.6× 153 1.2× 38 0.5× 83 1.3× 21 358
Efthymios Stavropoulos Greece 14 174 1.2× 134 1.0× 185 1.5× 113 1.5× 91 1.4× 17 459
Enrico De Lorenzis Italy 9 138 1.0× 61 0.4× 76 0.6× 29 0.4× 69 1.0× 40 281
Oliver J. Lawless United States 10 121 0.8× 51 0.4× 112 0.9× 40 0.5× 87 1.3× 17 328
Véronique Le-Guern France 7 260 1.8× 79 0.6× 100 0.8× 52 0.7× 132 2.0× 7 364
Isamu Yokoe Japan 10 71 0.5× 52 0.4× 116 0.9× 43 0.6× 39 0.6× 26 334
Susana Roverano Argentina 10 54 0.4× 98 0.7× 194 1.6× 27 0.4× 82 1.2× 27 341
Anne Günther Norway 10 67 0.5× 137 1.0× 74 0.6× 16 0.2× 159 2.4× 19 367
C. Heycock United Kingdom 8 34 0.2× 121 0.9× 151 1.2× 74 1.0× 65 1.0× 9 384

Countries citing papers authored by Andreas Bounas

Since Specialization
Citations

This map shows the geographic impact of Andreas Bounas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Bounas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Bounas more than expected).

Fields of papers citing papers by Andreas Bounas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Bounas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Bounas. The network helps show where Andreas Bounas may publish in the future.

Co-authorship network of co-authors of Andreas Bounas

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Bounas. A scholar is included among the top collaborators of Andreas Bounas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Bounas. Andreas Bounas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Karamanis, D., et al.. (2022). Anxiety, Distress, and Depression in Elderly Rheumatoid Arthritis Patients. Mediterranean Journal of Rheumatology. 33(4). 394–394. 6 indexed citations
4.
Psaltis, Dimitrios, Loukas Settas, A. Georgiadis, et al.. (2022). The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study. Rheumatology International. 42(4). 639–650. 1 indexed citations
5.
Kiltz, Uta, Petros P. Sfikakis, Karl Gaffney, et al.. (2022). Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab. Rheumatology and Therapy. 9(4). 1129–1142. 8 indexed citations
6.
Katsifis, Gikas, Andreas Bounas, Panagiotis Georgiou, et al.. (2022). Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study. Mediterranean Journal of Rheumatology. 33(Suppl 1). 162–162. 1 indexed citations
7.
Sidiropoulos, Prodromos, et al.. (2022). Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study. Mediterranean Journal of Rheumatology. 33(1). 14–14. 2 indexed citations
8.
Athanassiou, Panagiotis, Andreas Bounas, Theodoros Dimitroulas, et al.. (2021). The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the ‘GO-UP’ study. Quality of Life Research. 31(5). 1385–1399. 1 indexed citations
9.
Sidiropoulos, Prodromos, Andreas Bounas, Panagiotis Athanassiou, et al.. (2020). Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in Greece. Clinical Rheumatology. 39(12). 3643–3652. 7 indexed citations
10.
Mavrogeni, Sophie, Λουκία Κουτσογεωργοπούλου, George Markousis‐Mavrogenis, et al.. (2017). Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus. Lupus. 27(4). 564–571. 43 indexed citations
11.
Spiliopoulou, Iris, Antigoni Foka, Andreas Bounas, & Markos Marangos. (2014). Mycobacterium kansasiicutaneous infection in a patient with sarcoidosis treated with anti-TNF agents. Acta Clinica Belgica. 69(3). 229–231. 3 indexed citations
12.
Liossis, Stamatis‐Nick C., Andreas Bounas, & Andrew P. Andonopoulos. (2006). Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. Lara D. Veeken. 45(8). 1005–1008. 121 indexed citations
13.
Daoussis, Dimitrios, et al.. (2004). Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.. PubMed. 21(4 Suppl 30). S57–8. 16 indexed citations
14.
Andonopoulos, Andrew P., et al.. (2002). Asymptomatic gastrocnemius muscle biopsy: an extremely sensitive and specific test in the pathologic confirmation of sarcoidosis presenting with hilar adenopathy.. PubMed. 19(5). 569–72. 7 indexed citations
15.
Andonopoulos, A.P., et al.. (2001). Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography.. PubMed. 19(2). 187–90. 19 indexed citations
16.
17.
Christodoulou, J, et al.. (1998). Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study.. PubMed. 25(12). 2385–8. 60 indexed citations
18.
Andonopoulos, A.P., et al.. (1997). Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.. PubMed. 64(5). 287–92. 4 indexed citations
19.
Andonopoulos, Andrew P., et al.. (1996). Baker's cyst in rheumatoid arthritis: an ultrasonographic study with a high resolution technique.. PubMed. 13(5). 633–6. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasiliki Kalliopi Bournia Breakdown of academic impact, for papers by Raluca B Dumitru Breakdown of academic impact, for papers by Efthymios Stavropoulos Breakdown of academic impact, for papers by Enrico De Lorenzis Breakdown of academic impact, for papers by Oliver J. Lawless Breakdown of academic impact, for papers by Véronique Le-Guern Breakdown of academic impact, for papers by Isamu Yokoe Breakdown of academic impact, for papers by Susana Roverano Breakdown of academic impact, for papers by Anne Günther Breakdown of academic impact, for papers by C. Heycock
Rankless by CCL
2026